Source:http://linkedlifedata.com/resource/pubmed/id/16247223
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2005-10-25
|
pubmed:abstractText |
A 13-year old boy with acute lymphoblastic leukemia had bilateral paresis of the upper extremities and aphasia 1 week after high dose methotrexate and triple intrathecal therapy (methotrexate, cytarabin, hydrocortisone). The stroke-like neurological symptoms disappeared on the third day. T2-weighted magnetic resonance imaging showed hyperintensities of white matter on the second day. Despite resolution of the neurological symptoms, magnetic resonance images were still abnormal 3 years after the attack. Methotrexate has been considered to be responsible for ischemic damage to oligodendroglial cells, resulting in demyelination. The changes are occasionally prolonged without persistent neurologic symptoms.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1345-4676
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
252-3
|
pubmed:dateRevised |
2011-8-1
|
pubmed:meshHeading |
pubmed-meshheading:16247223-Adolescent,
pubmed-meshheading:16247223-Antimetabolites, Antineoplastic,
pubmed-meshheading:16247223-Brain,
pubmed-meshheading:16247223-Humans,
pubmed-meshheading:16247223-Magnetic Resonance Imaging,
pubmed-meshheading:16247223-Male,
pubmed-meshheading:16247223-Methotrexate,
pubmed-meshheading:16247223-Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
pubmed:year |
2005
|
pubmed:articleTitle |
Brain white matter changes during treatment of a child for acute lymphoblastic leukemia.
|
pubmed:affiliation |
Department of Pediatrics, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan. maeda@nms.ac.jp
|
pubmed:publicationType |
Journal Article,
Case Reports
|